| scholarly article | Q13442814 |
| P2093 | author name string | Jing Zhang | |
| Bin Wang | |||
| Dominic Ryan | |||
| Anu Daniel | |||
| Blaise Lippa | |||
| Brian Chamberlain | |||
| Chester A Metcalf | |||
| Douglas Bevan | |||
| Felix Epie | |||
| Jan Antoinette C Romero | |||
| Jared Silverman | |||
| Joseph Shotwell | |||
| Katherine M Poutsiaka | |||
| Kien Nguyen | |||
| Nicole Carter | |||
| Qingyi Yang | |||
| Roland E Dolle | |||
| Terence Moy | |||
| Vipul Kumar | |||
| Jason Cross | |||
| Anu Arya | |||
| Yuchuan Wu | |||
| P2860 | cites work | Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase | Q27660378 |
| Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents | Q28538023 | ||
| Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening | Q31406783 | ||
| Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 | ||
| Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents | Q36907300 | ||
| Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases. | Q38162903 | ||
| The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography | Q41064279 | ||
| 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV. | Q43291231 | ||
| Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationship | Q44006954 | ||
| Structure-activity relationship (SAR): effort towards blocking N-glucuronidation of indazoles (PF-03376056) by human UGT1A enzymes | Q46056539 | ||
| A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties | Q83570903 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1080-1085 | |
| P577 | publication date | 2015-09-08 | |
| P1433 | published in | ACS Medicinal Chemistry Letters | Q2819061 |
| P1476 | title | Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors | |
| P478 | volume | 6 |
| Q48266288 | Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors. |
| Q35994500 | Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design |
| Q57265865 | New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity |
| Q91666978 | Synthesis and biological evaluation against Leishmania donovani of novel hybrid molecules containing indazole-based 2-pyrone scaffolds |
| Q46478240 | Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis |
| Q38855273 | Targeting bacterial topoisomerases: how to counter mechanisms of resistance |
| Q47743532 | cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339. |
Search more.